Adalimumab or etanercept as first line biologic therapy in enthesitis related arthritis (ERA) - a drug-survival single centre study spanning 10 years-Reference-Cited by-同舟云学术

Adalimumab or etanercept as first line biologic therapy in enthesitis related arthritis (ERA) - a drug-survival single centre study spanning 10 years

Published:2022-08 Issue: Volume:55 Page:152038
ISSN:0049-0172
Container-title:Seminars in Arthritis and Rheumatism
language:en
Short-container-title:Seminars in Arthritis and Rheumatism

Author:

Shipa Muhammad RA^ORCID,Heyer Nicola,Mansoor Rashid,Deakin Claire T.,Madenidou Anastasia-Vasiliki,Bouraioui Aicha,Fisher Corinne,Leandro Maria,Ciurtin Coziana,Sen Debajit

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Rheumatology

Reference27 articles.

1. Long-term outcomes in juvenile idiopathic arthritis: eighteen years of follow-up in the population-based nordic juvenile idiopathic arthritis cohort;Glerup;Arthritis Care Res (Hoboken),2020

2. Enthesitis-related arthritis is associated with higher pain intensity and poorer health status in comparison with other categories of juvenile idiopathic arthritis: the childhood arthritis and rheumatology research alliance registry;Weiss;J Rheumatol,2012

3. 2019 American college of rheumatology/arthritis foundation guideline for the treatment of juvenile idiopathic arthritis: therapeutic approaches for non-systemic polyarthritis, sacroiliitis, and enthesitis;Ringold;Arthritis Care Res (Hoboken),2019

4. Clinical Commissioning Policy Statement: Biologic Therapies for the treatment of Juvenile Idiopathic Arthritis (JIA). NHS England [Internet]. Reference: NHS England E03X04.

5. Guidance on the use of etanercept for the treatment of juvenile idiopathic arthritis. NICE (National institute for health and care excellence). 2002 (Technology appraisal guidance [TA35]).

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Survival of Subcutaneous Biosimilar Tumor Necrosis Factor Inhibitors Compared to Originators: Results From a Multicenter Prospective Registry;The Journal of Rheumatology;2024-06-01

2. Choice and switch of biologic drugs in juvenile idiopathic arthritis;The Turkish Journal of Pediatrics;2023-12-25

3. Comparison of Treatment Options for Enthesitis-Related Arthritis with the Juvenile Spondyloarthritis Disease Activity Index;Medical Bulletin of Haseki;2023-09-27

4. Enthesitis-related arthritis in children: A literature review of the clinical features and differential diagnosis;Pediatric Traumatology, Orthopaedics and Reconstructive Surgery;2023-04-08

5. Recent updates in enthesitis-related arthritis;Rheumatology International;2023-01-11